logo

CDNA

CareDx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CDNA fundamentals

CareDx (CDNA) released its earnings on Nov 4, 2025: revenue was 100.10M (YoY +20.77%), beat estimates; EPS was 0.28 (YoY +100.00%), beat estimates.
Revenue / YoY
100.10M
+20.77%
EPS / YoY
0.28
+100.00%
Report date
Nov 4, 2025
CDNA Earnings Call Summary for Q3,2025
  • Revenue Growth: Q3 2025 revenue up 21% YoY to $100.1M, with Testing Services leading at +19%.
  • New Product Momentum: HistoMap Kidney (Q2 2026 launch) and AlloSeq Tx11 enhance diagnostic offerings.
  • Operational Excellence: 20% order turnaround time reduction via EPIC, 124% cash collections vs. Testing Services revenue.
  • Guidance Raise: 2025 revenue updated to $372M-$376M, EBITDA to $35M-$39M, reflecting strong RCM performance.
EPS
Revenue

Revenue & Expenses

CDNA has released its 2025 Q3 earnings report, with revenue of 100.06M, reflecting a YoY change of 20.72%, and net profit of 1.68M, showing a YoY change of 115.75%. The Sankey diagram below clearly presents CDNA's revenue sources and cost distribution.

Key Indicators

CareDx (CDNA) key financial stats and ratios, covering profitability, financial health, and leverage.
CareDx (CDNA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
CareDx (CDNA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
CareDx (CDNA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does CareDx (CDNA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track CareDx (CDNA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield